Valerie Wasinger

Dr Valerie Wasinger is a researcher at the Bioanalytical Mass Spectrometry Facility within the Mark Wainwright Analytical Centre at the University of New South Wales (UNSW). She is recognized as a pioneer in proteomics, notably as the first author of the foundational paper that defined the term 'proteomics' through studies on Mycoplasma genitalium. Her work spans medical biochemistry, metabolomics, and paleoproteomics, with a focus on translating proteomic techniques into clinical applications such as IBD, cancer, and forensic research.

• Supervision of PhD, Honours, Masters, and ILP students
• Contributions to discovery research in proteomics and -omics technologies
• Expertise in commercialization of biotech innovations

Dr Wasinger has led to two patents in IBD research and collaborates with national and international institutions. Her work emphasizes interdisciplinary partnerships and real-world translation of discovery research.

She operates within the Mark Wainwright Analytical Centre, a leading shared facility in Australia, and contributes to UNSW's mission of transforming research into tangible outcomes through entrepreneurial initiatives and industry partnerships.